Chennai, January 22, 2021: Caplin Point Laboratories Limited (BSE: CAPPL (524742),NSE: CAPLIPOINT) Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Argatroban Injection, 50 mg/50 ml (1 mg/ml) Single-dose vial presentation,…
Chennai, Jan 18, 2021: Caplin Point Laboratories Limited (BSE: CAPLL (524742), NSE: CAPLIPOINT) announced that Caplin Steriles Limited (a Subsidiary of Caplin Point Laboratories Ltd) has entered into a strategic partnership with JAMP Pharma Group for six injectable products to be filed shortly in Canada. Some of these products have already been filed by Caplin…
Chennai, December 24, 2020: Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT) Caplin Steriles Limited, a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Etomidate injection USP, 20 mg/10 mL (2 mg/mL) and 40 mg/20 mL (2 mg/mL) Single-dose vial presentations, a generic therapeutic equivalent version of (RLD),…
